Note also that these results contrast the MHCII+ CD11b+ profile obtained for PBMCs (Fig. 4b) and suggest a stroke-dependent modulation of MHCII regulatory mechanisms in the spleen, despite spleen atrophy. This evidence concerns the gene ITGAM and stroke disorder.